Physician profile
Jo Hsin Chen
NPI 1578771606
$7,129.21
in general payments reported to CMS, 2019-2025
53 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2020: $711 · 2021: $667 · 2022: $905 · 2023: $897 · 2024: $919 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,854 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,853.72 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,219.87 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $620.83 | 2019-2022 | |
| Lilly USA, LLC | $598.69 | 2019-2025 | Reyvow, Emgality, Amyvid |
| Abbvie INC. | $484.34 | 2021-2025 | Ubrelvy, Qulipta |
| Biogen, INC. | $327.22 | 2019-2025 | Vumerity, Tysabri |
| Lundbeck LLC | $245.89 | 2019-2025 | Vyepti |
| Pfizer INC. | $243.93 | 2023-2025 | |
| Genzyme Corporation | $223.41 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $217.17 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $203.60 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $203.38 | 2021-2025 | Hyqvia, Gammagard |
| Argenx US, INC. | $199.18 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $169.83 | 2019-2025 | Rystiggo, Zilbrysq |
| Eisai INC. | $167.46 | 2019-2023 | |
| Amgen INC. | $163.27 | 2019-2025 | Uplizna |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jo Hsin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.